ISR knows that selecting a CRO is not easy. There are a myriad of factors to evaluate for each CRO being considered. Does the provider have the necessary therapeutic expertise? Will the project be completed on time and within budget? Will the provider have sufficient access to necessary resources? Without prior experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased assessments of CRO performance passed on through word of mouth from peers within the industry. In this Benchmarking report, ISR provides the data necessary to answer these questions – and many more – with confidence. 101 decision-makers have weighed in with their Preclinical CRO selection criteria and outsourcing behaviors. They have provided feedback on 446 recent service encounters across 42 Preclinical CROs. 18 providers have received detailed service quality profiles.

1. CRO
QUALITY
BENCHMARKING
PRECLINICAL
CRO Quality
Benchmarking –
Preclinical Service
Providers
Info@ISRreports.com
©2014 Industry Standard Research www.ISRreports.com
PREVIEW

2. Report Structure:
Service Encounters 1. Outsourcing Behaviors, Attitudes, Beliefs, and Intentions
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 2
act with confidence
Report Overview
ISR knows that selecting a CRO is not easy. There are a myriad of factors to evaluate for each CRO being
considered. Does the provider have the necessary therapeutic expertise? Will the project be completed
on time and within budget? Will the provider have sufficient access to necessary resources? Without prior
experience with a provider, purchasers of CRO services are often forced to rely on incomplete or biased
assessments of CRO performance passed on through word of mouth from peers within the industry.
In this Benchmarking report, ISR provides the data necessary to answer these questions – and many
more – with confidence. 101 decision-makers have weighed in with their Preclinical CRO selection
criteria and outsourcing behaviors. They have provided feedback on 446 recent service encounters
across 42 Preclinical CROs. 18 providers have received detailed service quality profiles.
446
101
Respondents
333
Charts and Graphs
176
Pages
• Preclinical Leaders
• Proposal Volume
• Service Provider Usage
• Service Provider Preference
• Service Provider Cost Experience and Perceptions
2. Service Provider Selection Drivers
• Most Important Service Provider Attributes
• Service Provider Attributes Gaining Importance
3. Service Provider Performance and Scorecards Across Attributes
• Staff Characteristics Ratings
• Operational Excellence Ratings
• Organizational and Finance Ratings
• Performance Summary by Category
• Service Provider Loyalty
4. Service Provider Service Quality Profiles
5. All Study Data
How you can use this report:
Study Sponsors
• Make a more informed purchase of Preclinical
services by understanding which service
providers best fit your company’s needs
• Broaden your Preclinical CRO evaluation list
by accessing peer-based service quality ratings
across critical attributes
• Pinpoint potential delivery concerns early
in a CRO relationship/ evaluation in order
to develop proactive strategies to address
potential gaps
Preclinical Service Providers
• Uncover your own — and competitor —
delivery strengths and weaknesses
• Design messaging to tout your company’s
strengths
• Compete more effectively by understanding
buyers’ selection criteria and outsourcing
trends

3. CROs Included in this Report
• Absorption Systems
• Accelera
• Alliance Pharma Inc.
• Aptiv Solutions
• Aptuit
• Avanza Laboratories
• BASi
• BioDuro
• BioReliance
• BRI Biopharmaceutical
• CeeTox
• Cellular Technology Limited
• CiToxLab
• Covance
• EMD Millipore
• Frontage Laboratories
• Harlan
• Huntington Life Sciences
• IITRI
• Indivumed GmbH
• Maccine
• MD Biosciences
• MDS Pharma
• MicroConstants
• MPI Research
• Myriad RBM
• Quotient BioResearch
Participant Job Title Participant Geography Participant Company Size
34% Europe
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 3
act with confidence
Research Calvert
(CTL)
• Charles River Laboratories
Service Quality Metrics
• Ricerca
• Sequani
• Sirius Analytical
• SNBL
• Southern Research
• SRI International, Biosciences
Division
• Taconic
• Toxicon
• Wil Research
• William Harvey Research
• WuXi AppTec
• XenoBiotic Laboratories
• XenoTech
11% C-level
13% President/ VP
53% Director
23% Manager
45% Large Companies
(R&D $1B or more)
33% Mid-Size
Companies (R&D
$100M-$999M)
28% Small Companies
(R&D less than $100M)
61%
North America
5%
Asia /
Other
Report Metrics
Respondent Demographics (N=101)
Participant Experience: Mean = 15.5 years
• Experience of the
Preclinical unit’s lead
investigator
• Local market / Regulatory
knowledge
• Project manager quality
• Project team chemistry
• Provider responsiveness to
sponsor’s questions
• Scientific knowledge
• Therapeutic expertise
• Access to “unique” tests,
machines, equipment
• Data quality metrics
• Detailed plan for timely
project communications
• Experience conducting
specific tests and assays
• Metrics for database lock
timelines
• Metrics for meeting overall
project timelines
• Offers innovative solutions
• Prior positive experience
with service provider
• Technology for real-time
access to data
• Up-front contingency
planning, risk management
• Financial strength/ stability
• Location of Preclinical
unit(s) in different global
regions
• Location of Preclinical
unit(s) within your country
• Low cost
• Staff turnover metrics

4. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 4
act with confidence
Table of Contents
For full table of contents and additional sample pages, download the full pre-view
from: www.isrreports.com/product/cro-quality-benchmarking-preclini-cal-
service-providers/

5. Introduction
Welcome to ISR’s CRO Quality Benchmarking Preclinical Service Providers report.
Over time, Industry Standard Research has accumulated a wealth of knowledge
around service quality and CRO performance. Understanding and utilizing this
information allows stakeholders within the industry to make informed decisions
when choosing a CRO for Preclinical services.
ISR knows that selecting a CRO is not easy. There are a myriad of factors to
evaluate for each CRO being considered. Does the provider have the necessary
therapeutic expertise? Will the project be completed on time and within budget?
Will the provider have sufficient access to necessary resources? Without prior
experience with a provider, purchasers of CRO services are often forced to rely on
incomplete or biased assessments of CRO performance passed on through word
of mouth from peers within the industry.
In this Benchmarking report, ISR provides the data necessary to answer these
questions – and many more – with confidence. 101 decision-makers have weighed
in with their Preclinical CRO selection criteria and outsourcing behaviors. They
have provided feedback on 446 recent service encounters across 42 Preclinical
CROs. 18 providers have received detailed service quality profiles.
Not only does this report enable more educated purchases of Preclinical CRO
services, it also allows Preclinical service providers to get a behind-the-scenes
look at customers’ perceptions of their performance. Providers can determine
areas of strength and understand where they may need to close the gap relative
to competitors. As they say, knowledge is power. Having a grasp on customer
beliefs, attitudes, and experiences will help Preclinical CROs effectively promote
strengths and improve areas of weakness.
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 5
act with confidence
act with confidence
Introduction
www.ISRreports.com ©2014 | CRO Quality Benchmarking Preclinical Service Providers 7
Sample Page

6. Sample Page
Figure 1 – Staff Characteristics Ratings
Figure 1 – Staff Characteristics
Ratings
Scientific
knowledge
Local
market /
Regulatory
knowledge
Sta Characteristics
Project
team
chemistry
Project
manager
quality
Provider
responsiveness
to sponsor’s
questions
Therapeutic
expertise
Experience of
the Preclinical
unit’s lead
investigator
Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 6
act with confidence
act with confidence
Service Provider Performance and Scorecards Across Attributes
www.ISRreports.com ©2014 | CRO Quality Benchmarking Preclinical Service Providers 29
Company A
Company B
Absorption Systems
Company C
Aptiv Solutions
Company D
Aptuit
Company E
Company F
BioReliance
Charles River Laboratories
Company G
Company H
CiToxLab
Company I
Covance
Company J
EMD Millipore
Company K
Frontage Laboratories Inc.
Company L
Harlan
Company M
Huntington Life Sciences
Company N
MDS Pharma
Company O
MPI Research
Company P
Myriad RBM
Company Q
Quotient BioResearch
Company R
Ricerca
Wuxi Apptech
XenoTech
Scientific
knowledge
Local
market /
Regulatory
knowledge
Project
team
chemistry
Project
manager
quality
Provider
responsiveness
to sponsor’s
questions
Therapeutic
expertise
Experience of
the Preclinical
unit’s lead
investigator
Sta‚ Characteristics
Ratings Key: Clear leadership Better than most About average Falling a bit short Likely deficiency

7. www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 7
act with confidence
Sample Page
For full table of contents and additional sample pages, download the full pre-view
from: www.isrreports.com/product/cro-quality-benchmarking-preclini-cal-
service-providers/

8. For pricing and ordering information, visit ISR’s website: www.isrreports.com/
product/cro-quality-benchmarking-preclinical-service-providers/
Save on this,
or any ISR
report, by
registering a
free account
Register now
• Receive a $250 instant credit towards any ISR report
• Earn 10% credit towards all future purchases
• Receive advanced notifications on ISR’s latest reports and free resources
About Industry Standard Research
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 8
act with confidence
Ordering Information
Industry Standard Research (ISR) is the premier, full service market research provider to the pharma and pharma services
industries. With over a decade of experience in the industry, ISR delivers an unmatched level of domain expertise.
For more information about our off-the-shelf intelligence and custom research offerings, please visit our Web site at
www.ISRreports.com, email info@ISRreports.com, or follow us on twitter @ISRreports.

9. The ISR Difference
Custom-quality syndicated market research
www.ISRreports.com
vs. Syndicated Report
ISR's Reports The Common
How confident are you?
Research methods
Data Collection
vs.
Respondents
Sample Sizes
Analysts
www.ISRreports.com ©2014 | Preview of: CRO Quality Benchmarking – Preclinical Service Providers 9
act with confidence
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions 9
www.ISRreports.com ©2014 | Preview of: Benchmarking European Investigator Payments 10
www.ISRreports.com ©2013 | Preview of: Benchmarking the Pharma Industry’s HEOR Functions ISR's proprietary data collection
tools and channels support fast,
high quality data collection
Struggle to recruit the right
targets and enough of them
vs.
Robust sample sizes that
instill confidence
Often insufficient industry
representation that leaves you
defending results
vvss..
Mostly primary
research;
always appropriate
for the topic
One size fits all;
usually publically
available data
vvss..
Sophisticated screening
ensures genuine
decision-makers
Undisclosed
methodologies and
respondent demographics
vvss..
Decades of experience
means more insights that are
immediately usable
Junior analysts capable of
reporting numbers